drugset / Trial / NCT06050291

Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe

NCT06050291

Phase 1 Completed 28 enrolled NewAmsterdam Pharma
RandomizedCrossoverOpen-labelTreatment

Summary

This study will assess the effect of food on the bioavailability of obicetrapib and ezetimibe after a single-dose administration of a fixed-dose combination formulation of obicetrapib/ezetimibe, 10 mg/10 mg in healthy adult male and female subjects under fasted and fed conditions.

Timeline

Start
2024-01-20
Primary completion
2024-04-07
Completion
2024-04-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg
Subject Obicetrapib Small molecule 10 mg

Indications

No indication recorded.